Primary lymphoma of brain: Results of management of a modern cohort with radiation therapy

被引:36
作者
Laperriere, NJ
Cerezo, L
Milosevic, MF
Wong, CS
Patterson, B
Panzarella, T
机构
[1] UNIV TORONTO, TORONTO, ON, CANADA
[2] PRINCESS MARGARET HOSP, ONTARIO CANC INST, DEPT ONCOL PATHOL, TORONTO, ON M4X 1K9, CANADA
[3] PRINCESS MARGARET HOSP, ONTARIO CANC INST, DEPT BIOSTAT, TORONTO, ON M4X 1K9, CANADA
[4] HOSP PRINCESA, SERV RADIOTERAPIA, MADRID, SPAIN
关键词
primary non-Hodgkin's lymphoma of brain; CNS lymphoma; radiation therapy; prognostic factors;
D O I
10.1016/S0167-8140(97)00074-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the outcome and prognostic factors for patients with primary lymphoma of brain managed with radiation therapy between 1979 and 1988. Methods and materials: A retrospective review was undertaken of 49 patients referred to Princess Margaret Hospital. There were 25 males and 24 females. Median age was 60 years, with a range of 17-80 years. Tumors were located supratentorially in 35, infratentorially in 10, and both in 4 patients. Single masses were demonstrated on CT brain in 36, and multiple lesions in 13 patients. Cranial irradiation was given in 48, and 11 patients received chemotherapy. All patients in this series were immunocompetent. Results: Over a follow-up range of 3-11 years of surviving patients, with a median of 6 years, 40/49 patients have died. Overall median survival was 1.4 years (17 months) and 5-year actuarial survival was 26%. Statistical analysis revealed the following significant factors: Karnofsky performance status (KPS), age, and distribution pattern of disease on presenting CT brain. Five-year actuarial survival for patients with a KPS > 60 or < 60 was 56% and 10%, respectively (P = 0.01); for patients with age < 60 or > 60, 5-year actuarial survival was 42% and 9%, respectively (P = 0.03); for patients with solitary or multiple lesions, 5-year actuarial survival was 30% and 15%, respectively (P = 0.04). Conclusions: We conclude that Karnofsky performance status, age, and distribution pattern on pretreatment CT of brain are significant prognostic factors in primary lymphoma of brain, and that new approaches need to be developed for these patients. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 28 条
[1]  
ASHBY MA, 1988, CLIN RADIOL, V39, P173
[2]   RADIATION-THERAPY IN THE MANAGEMENT OF PRIMARY MALIGNANT-LYMPHOMA OF THE BRAIN [J].
BERRY, MP ;
SIMPSON, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (01) :55-59
[3]   PRIMARY CEREBRAL MALIGNANT NON-HODGKINS-LYMPHOMAS - A RETROSPECTIVE CLINICAL-STUDY [J].
BRAUS, DF ;
SCHWECHHEIMER, K ;
MULLERHERMELINK, HK ;
SCHWARZKOPF, G ;
VOLK, B ;
MUNDINGER, F .
JOURNAL OF NEUROLOGY, 1992, 239 (03) :117-124
[4]  
Deangelis L M, 1995, Oncology (Williston Park), V9, P63
[5]   PRIMARY CNS LYMPHOMA - COMBINED TREATMENT WITH CHEMOTHERAPY AND RADIOTHERAPY [J].
DEANGELIS, LM ;
YAHALOM, J ;
HEINEMANN, MH ;
CIRRINCIONE, C ;
THALER, HT ;
KROL, G .
NEUROLOGY, 1990, 40 (01) :80-86
[6]   COMBINED MODALITY THERAPY FOR PRIMARY CNS LYMPHOMA [J].
DEANGELIS, LM ;
YAHALOM, J ;
THALER, HT ;
KHER, U .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :635-643
[7]  
DEVESA SS, 1992, CANCER RES, V52, pS5432
[8]  
EBY NL, 1988, CANCER, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO
[9]  
2-M
[10]  
FREEMAN CR, 1986, CANCER, V58, P1106, DOI 10.1002/1097-0142(19860901)58:5<1106::AID-CNCR2820580521>3.0.CO